Systems and Methods to Mitigate the Effects of Skin Moisture on a Percutaneous Infrared Signal

• US 20130237779A1
• Filed: 03/10/2013
• Published: 09/12/2013
• Est. Priority Date: 03/12/2012
• Status: Abandoned Application

• Current Assignee: ivWatch, LLC
• Original Assignee: Gary P. Warren, ivWatch, LLC, Matthew S. Alley
• Inventors: Warren, Gary P., Alley, Matthew S.
• Application Number:
  US13/792,096
• Publication Number:
  US 20130237779A1
• Time in Patent Office: Days
• US Class Current: 600/306
• CPC Class Codes: A61M 5/16836 by sensing tissue properties at the infusion site, e.g. for detecting infiltration detecting tissue temperature for diagnostic purposes A61M39/0247

Abstract

A system and method include a sensor overlying a target area of epidermis to aid in diagnosing subcutaneous fluid leakage. The system includes an antiperspirant and an adhesive coupling the sensor and epidermis. The antiperspirant mitigates moisture content variation of the target area, which the inventors discovered is a source of unreliable indications that an infiltration or extravasation event has occurred.

Claims

1. A system for monitoring an intravascular infusion, the apparatus comprising:

a sensor configured to emit a first percutaneous electromagnetic signal and to receive a second percutaneous electromagnetic signal, the second percutaneous electromagnetic signal including at least one of a reflection, scattering and diffusion of the first percutaneous electromagnetic signal; and

antiperspirant configured to be disposed at a target area of epidermis, wherein the first and second percutaneous electromagnetic signals pass through the target area.

2. The system of claim 1 wherein the first and second percutaneous electromagnetic signals comprise near-infrared signals.

3. The system of claim 1 wherein the first percutaneous electromagnetic signal is configured to impinge on perivascular tissue, and wherein the second percutaneous electromagnetic signal includes at least one of reflection, scattering and diffusion of the first percutaneous electromagnetic signal by the perivascular tissue.

4. The system of claim 1, comprising a barrier film configured to coat the target area with a protective layer.

5. The system of claim 4 wherein the barrier film consists of at least one of Cavilon™

and Skin-Prep™

.

6. A system for monitoring a subcutaneous anatomical property of a body that includes an epidermis, the system comprising:

a first sensor configured to overlie a target area of the epidermis and to receive a first signal regarding the subcutaneous anatomical property; and

a second sensor configured to receive a second signal regarding moisture content of the target area of the epidermis.

7. The system of claim 6 wherein the first sensor comprises an aid to diagnosing at least one of infiltration and extravasation.

8. The system of claim 6 wherein the first signal comprises a near-infrared electromagnetic signal.

9. The system of claim 6 wherein the second signal comprises a visible light electromagnetic signal.

10. The system of claim 6 wherein the second sensor comprises at least one of an epidermal resistance sensor, an epidermal impedance sensor, and an epidermal temperature sensor.

11. The system of claim 6 wherein the second sensor comprises at least one of a magnetic field sensor and an electrical field sensor.

12. The system of claim 6, comprising a processor including an algorithm receiving the first and second signals, wherein the algorithm compensates the first signal for variations in the moisture content of the target area based on the second signal.

13. A method of sensing fluid in perivascular tissue, the method comprising:

applying an antiperspirant to a target area of epidermis; and

coupling a sensor to the epidermis, the sensor being configured to emit and detect near-infrared signals through the target area.

14. The method of claim 13 wherein applying the antiperspirant comprises distributing on the target area a layer consisting of at least one of aluminum chloride, aluminum zirconium, aluminum chlorohydrate, aluminum hydroxybromide, crystal alum and talc.

15. The method of claim 13 wherein the sensor includes a foundation and coupling the sensor comprises adhering the foundation to the epidermis.

16. The method of claim 15 wherein the foundation comprises a medical grade adhesive that is biocompatible according to at least one of ISO 10993 and USP Class VI.

17. The method of claim 16 wherein the foundation comprises a panel that is generally transparent to the near-infrared signals.

18. The method of claim 13 wherein coupling the sensor comprises overlaying a dressing on the epidermis and inserting the sensor in the dressing over the target area.

19. The method of claim 13, comprising cleaning the target area with an antiseptic.

20. The method of claim 13, comprising protecting the epidermis with a barrier film.